Heydemann A - Search Results

1

Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy.

Heydemann A, McNally EM. Heydemann A, et al. Trends Cardiovasc Med. 2007 Feb;17(2):55-9. doi: 10.1016/j.tcm.2006.12.002. Trends Cardiovasc Med. 2007. PMID: 17292047 Review.

2

Cardiomyopathy in animal models of muscular dystrophy.

Heydemann A, Wheeler MT, McNally EM. Heydemann A, et al. Curr Opin Cardiol. 2001 May;16(3):211-7. doi: 10.1097/00001573-200105000-00009. Curr Opin Cardiol. 2001. PMID: 11357018 Review.

3

Cytoskeletal defects in cardiomyopathy.

McNally E, Allikian M, Wheeler MT, Mislow JM, Heydemann A. McNally E, et al. Among authors: heydemann a. J Mol Cell Cardiol. 2003 Mar;35(3):231-41. doi: 10.1016/s0022-2828(03)00018-x. J Mol Cell Cardiol. 2003. PMID: 12676538 Review.

4

The sarcoglycan complex in striated and vascular smooth muscle.

Wheeler MT, Allikian MJ, Heydemann A, McNally EM. Wheeler MT, et al. Among authors: heydemann a. Cold Spring Harb Symp Quant Biol. 2002;67:389-97. doi: 10.1101/sqb.2002.67.389. Cold Spring Harb Symp Quant Biol. 2002. PMID: 12858564 Review. No abstract available.

5

Functional nitric oxide synthase mislocalization in cardiomyopathy.

Heydemann A, Huber JM, Kakkar R, Wheeler MT, McNally EM. Heydemann A, et al. J Mol Cell Cardiol. 2004 Feb;36(2):213-23. doi: 10.1016/j.yjmcc.2003.09.020. J Mol Cell Cardiol. 2004. PMID: 14871549

6

Smooth muscle cell-extrinsic vascular spasm arises from cardiomyocyte degeneration in sarcoglycan-deficient cardiomyopathy.

Wheeler MT, Allikian MJ, Heydemann A, Hadhazy M, Zarnegar S, McNally EM. Wheeler MT, et al. Among authors: heydemann a. J Clin Invest. 2004 Mar;113(5):668-75. doi: 10.1172/JCI20410. J Clin Invest. 2004. PMID: 14991064 Free PMC article.

7

Regenerating more than muscle in muscular dystrophy.

Heydemann A, McNally EM. Heydemann A, et al. Circulation. 2004 Nov 23;110(21):3290-2. doi: 10.1161/01.CIR.0000149847.84152.0B. Circulation. 2004. PMID: 15557384 No abstract available.

8

Transplanted hematopoietic stem cells demonstrate impaired sarcoglycan expression after engraftment into cardiac and skeletal muscle.

Lapidos KA, Chen YE, Earley JU, Heydemann A, Huber JM, Chien M, Ma A, McNally EM. Lapidos KA, et al. Among authors: heydemann a. J Clin Invest. 2004 Dec;114(11):1577-85. doi: 10.1172/JCI23071. J Clin Invest. 2004. PMID: 15578090 Free PMC article.

9

Genetic background influences muscular dystrophy.

Heydemann A, Huber JM, Demonbreun A, Hadhazy M, McNally EM. Heydemann A, et al. Neuromuscul Disord. 2005 Oct;15(9-10):601-9. doi: 10.1016/j.nmd.2005.05.004. Neuromuscul Disord. 2005. PMID: 16084087

10

Genetic modifiers of muscular dystrophy: implications for therapy.

Heydemann A, Doherty KR, McNally EM. Heydemann A, et al. Biochim Biophys Acta. 2007 Feb;1772(2):216-28. doi: 10.1016/j.bbadis.2006.06.013. Epub 2006 Jul 11. Biochim Biophys Acta. 2007. PMID: 16916601 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page